{"provider_name":"Hatena Blog","published":"2009-10-30 00:00:02","image_url":null,"author_name":"uneyama","version":"1.0","width":"100%","type":"rich","categories":["EFSA"],"provider_url":"https://hatena.blog","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Funeyama.hatenadiary.jp%2Fentry%2F20091030%2Fp3\" title=\"\u30b0\u30eb\u30b3\u30b5\u30df\u30f3\u5869\u9178\u3068\u8edf\u9aa8\u5909\u6210\u901f\u5ea6\u306e\u9045\u5ef6\u3068\u9aa8\u95a2\u7bc0\u708e\u30ea\u30b9\u30af\u524a\u6e1b\u306b\u95a2\u3059\u308b\u5065\u5eb7\u5f37\u8abf\u8868\u793a\u306e\u7acb\u8a3c\u306b\u95a2\u3059\u308b\u79d1\u5b66\u7684\u610f\u898b - \u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","title":"\u30b0\u30eb\u30b3\u30b5\u30df\u30f3\u5869\u9178\u3068\u8edf\u9aa8\u5909\u6210\u901f\u5ea6\u306e\u9045\u5ef6\u3068\u9aa8\u95a2\u7bc0\u708e\u30ea\u30b9\u30af\u524a\u6e1b\u306b\u95a2\u3059\u308b\u5065\u5eb7\u5f37\u8abf\u8868\u793a\u306e\u7acb\u8a3c\u306b\u95a2\u3059\u308b\u79d1\u5b66\u7684\u610f\u898b","author_url":"https://blog.hatena.ne.jp/uneyama/","height":"190","blog_url":"https://uneyama.hatenadiary.jp/","description":"Scientific Opinion on the substantiation of a health claim related to glucosamine hydrochloride and reduced rate of cartilage degeneration and reduced risk of development of osteoarthritis pursuant to Article 14 of Regulation (EC) No 1924/2006 29 October 2009 http://www.efsa.europa.eu/EFSA/efsa_loca\u2026","blog_title":"\u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b","url":"https://uneyama.hatenadiary.jp/entry/20091030/p3"}